Skip to main content

Table 1 Demographics and transplant characteristics, mean (SD), at baseline (8 weeks − 1 year after renal transplantation) -

From: Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

Variables Paricalcitol N = 37 Paricalcitol N = 37 No treatment N = 39 No treatment N = 39
Time point post Tx 8 weeks 1 year 8 weeks 1 year
Age (years) 56.0 (13.4) NA 54.2 (12.1) NA
Albumin (g/L) 42.4 (2.4) 43.3 (2.5) 41.7 (2.5) 43.3 (2.7)
ALP (U/L) 61.4 (21.7) 58.4 (20.5) 70.2 (28.0) 71.4 (33.4)
BMI (kg/m2) 26.1 (3.2) NA 25.5 (3.9) NA
Calcium, total (mmol/L) 2.4 (0.1) 2.4 (0.1) 2.4 (0.1) 2.4 (0.1)
Creatinine (μmol/L) 114.4(24.5) 110.3 (26.7) 120.9 (29.6) 114.6 (27.5)
Phosphate (mmol/L) 0.9 (0.2) 0.9 (0.1) 0.9 (0.3) 0.9 (0.1)
PTH (pmol/L) 11.5 (5.7) 7.9 (4.8) 11.4 (5.3) 9.9 (3.8)
T50 (min) 311 (35) 319 (34.5) 319 (34) 323 (35.6)
HLA mismatch 3.1 (1.3) NA 3.0 (1.4) NA
Gender (% male) 27 (73) NA 33 (84.6) NA
Smoking (% Yes) 5 (13.5) NA 5 (12.8) NA
Living donor (% Yes) 10 (27.0) NA 13 (33.3) NA
Predialytic transplantation (% Yes) 13 (31.1) NA 12 (30.8) NA
Pretransplant diabetes (% Yes) 7 (18.9) NA 6 (15.4) NA
  1. NA denotes not available. For clarity all figures are reported to two decimals
  2. Abbreviations: ALP alkaline phosphatase, BMI body mass index, PTH parathyroid hormone, T50; time to 50% transfer to crystalline particles, HLA human leukocyte antigen